New do the job confirms these findings but shows it to become a remarkably powerful mutagen that induces substantial genetic alterations in cultured human cells with or without the need of BRCA1/2 mutations, increasing significant basic safety concerns.Inherited BRCA2 mutations predispose carriers to early onset breast, ovarian along with other can